What is Avanos Medical Inc (AVNS) stock price today?

Avanos Medical Inc (AVNS) currently trades at $24.64 per share. The stock has a market capitalization of $1.15B and a P/E ratio of —x.

Is AVNS stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Avanos Medical Inc has a Smart Value Score of 34/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Avanos Medical Inc's revenue and earnings?

Avanos Medical Inc has trailing twelve-month (TTM) revenue of $701.20M with profit margins of -10.40%. Earnings per share (EPS) is $-1.57.

Is AVNS stock overvalued or undervalued?

Based on our DCF model, Avanos Medical Inc's intrinsic value is $64.45, representing a margin of safety of 76.54%. The stock currently trades at a P/E of —x.

AVNS

Avanos Medical Inc

NYSE: AVNS · HEALTHCARE · MEDICAL DEVICES

$24.64

-0.06% today

Updated 2026-04-30

Market cap

$1.15B

P/E ratio

—

P/S ratio

1.64x

EPS (TTM)

$-1.57

Dividend yield

—

52W range

$9 – $25

Volume

1.4M

Market cap

$1.15B

P/E ratio

—

P/S ratio

1.64x

EPS (TTM)

$-1.57

Dividend yield

—

52W range

$9 – $25

Volume

1.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.3

Growth

5.0

Quality

C+

3.0

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$14.00

-43.17%

12-Month target

—

Intrinsic (DCF)

$64.45

Margin of safety

+76.54%

0 Strong Buy0 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $21.30M — positive

+ 76.54% below intrinsic value

Risks

- Thin margins at -10.40%

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$684.10M	$673.30M	$687.80M	$701.20M	$701.20M
Net income	$50.50M	$-61.80M	$-392.10M	$-67.90M	$3.70M
EPS	—	—	—	—	$-1.57
Free cash flow	$71.60M	$14.60M	$82.90M	$43.10M	$21.30M
Profit margin	7.38%	-9.18%	-57.01%	-9.68%	-10.40%

Recent insider activity

Date	Insider	Type	Shares	Price
2026-03-13	PACITTI, DAVID	Buy	239,354	—
2026-03-13	PACITTI, DAVID	Buy	101,341	—
2026-03-13	HURLEY, JOHN JOSEPH	Buy	2,211	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
AVNS	$1.15B	34	3.3	3.0	6.7	5.0	+76.54%	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Avanos Medical Inc trades at $24.64. Our Smart Value Score of 34/100 indicates the stock is weak. TTM revenue stands at $701.20M. with profit margins at -10.40%. Our DCF model estimates intrinsic value at $64.45.

Frequently asked questions

What is Avanos Medical Inc's stock price?

Avanos Medical Inc (AVNS) trades at $24.64.

Is Avanos Medical Inc overvalued?

Smart Value Score 34/100 (Grade F, Strong Sell). DCF value $64.45.

What is the price target of Avanos Medical Inc (AVNS)?

The analyst target price is $14.00, representing -43.2% downside from the current price of $24.64.

What is the intrinsic value of Avanos Medical Inc (AVNS)?

Based on our DCF model, intrinsic value is $64.45, a +76.5% margin of safety versus $24.64.

What is Avanos Medical Inc's revenue?

TTM revenue is $701.20M.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNYSE

CurrencyUSD

Quick metrics

P/S ratio1.64x

ROE-9.08%

Beta1.05

50D MA$15.91

200D MA$12.82

Shares out0.05B

Float0.04B

Short ratio—

Avg volume1.4M

Performance

1 week+4.38%

1 month+5.14%

3 months+22.41%

YTD+29.39%

1 year—

3 years—

5 years—

Compare

AVNS vs LLY →AVNS vs JNJ →AVNS vs ABBV →Stock screener →